A Study to Compare Pharmacodynamics and Pharmacokinetics of Insulin Glargine 300 U/mL (Toujeo®) to Insulin Degludec (Tresiba®) Under Steady State in Subjects with Type 1 Diabetes Mellitus (T1DM)

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To compare the pharmacodynamic profile of Toujeo with Tresiba in steady state in a euglycemic clamp after 8 days once daily dosing regimen at 2 dose levels in T1DM patients

Critère d'inclusion

Type1 Diabetes Mellitus

Liens

ictrp
euctr